北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (5): 805-810. doi: 10.19723/j.issn.1671-167X.2018.05.007

• 论著 • 上一篇    下一篇

乳头状肾细胞癌合并癌栓患者的临床病理分析

丁振山,邱敏,徐梓程,肖若陶,葛力源,马潞林△   

  1. (北京大学第三医院泌尿外科, 北京100191)
  • 出版日期:2018-10-18 发布日期:2018-10-18
  • 通讯作者: 马潞林 E-mail:malulin@medmail.com.cn

Clinicopathological analysis of patients with papillary renal cell carcinoma complicated by tumor thrombus

DING Zhen-shan,QIU Min,XU Zi-cheng,XIAO Ruo-tao,GE Li-yuan,MA Lu-lin△   

  1. (Department of Urology, Peking University Third Hospital, Beijing 100191, China)
  • Online:2018-10-18 Published:2018-10-18
  • Contact: MA Lu-lin E-mail:malulin@medmail.com.cn

摘要: 目的:探讨乳头状肾细胞癌(papillary renal cell carcinoma,PRCC)以及PRCC合并癌栓患者的临床病理特点、治疗及预后。方法:回顾性分析单中心2012年1月至2017年10月收治的75例PRCC的病例,其中男性55例,女性20例,年龄24~82岁,合并癌栓的患者16例,所有病例均为手术患者,病理诊断明确,随访数据完整。总结分析PRCC以及合并癌栓患者的临床病理特点、预后及影响因素。结果:75例患者平均年龄(56.05±11.59)岁,平均体重指数(26±3) kg/m2,肿瘤平均最大径(5.17±3.85) cm,肿瘤最大径是否大于7 cm(69.6%vs.94.4%,P<0.001),有无淋巴结转移(<38%vs.98%,P<0.001)、有无肾上腺转移(0% vs.95.3%,P<0.001)、有无肺转移(0% vs.90.7%,P<0.001)、是否合并癌栓(<66.4%vs.93.5%,P<0.001)对PRCC患者3年生存率的影响差异有统计学意义。本研究患者中,合并癌栓患者16例,16例患者均为2型PRCC。合并癌栓的患者在有无伴随症状(62.5% vs. 22%,P=0.005)、肿瘤最大径(68.8% vs.13.3%,P<0.001)、有无肾上腺转移(18.8% vs.0.02%, P=0.029)、有无肺转移(18.8% vs.0%,P=0.008)、核分级(P<0.001)以及病理分型(100% vs.44.1%,P<0.001)方面,与不合并癌栓患者的差异有统计学意义。结论:肿瘤最大径、淋巴结转移、肾上腺转移、肺转移、是否合并癌栓是PRCC患者3年生存率的影响因素;本研究中合并癌栓的PRCC患者均为2型,肿瘤直径更大、核分级更高、更容易发生远处转移。

关键词: 乳头状肾细胞癌, 癌栓, 生存率

Abstract: Objective: To investigate the clinicopathological features,treatment and prognosis of patients with papillary renal cell carcinoma (PRCC) and PRCC-complicated with tumor thrombus. Me-thods: Single center retrospective analysis of 75 patients with PRCC treated from January 2012 to October 2017 was performed. There were 55 males and 20 females at an age range of 24-82 years. Sixteen PRCC patients were complicated with tumor thrombus. All the patients were with a surgery and had clear pathological diagnosis and detailed follow-up data. The clinicopathological features,prognosis and influencing factors of the patients with PRCC and PRCC complicated with tumor thrombus were analyzed and summarized. Results: The average age of the 75 patients was(56.05±11.59)years,the average body mass index (BMI) was (26±3) kg/m2, and the average tumor maximum diameter was(5.17±3.85)cm. There were significant differences between tumor maximum diameter larger than 7 cm and less than 7 cm (69.6% vs. 94.4%, P<0.001), lymph node metastasis and no lymph node metastasis (<38% vs. 98%, P<0.001), adrenal metastasis and no adrenal metastasis (0% vs. 95.3%, P<0.001), pulmonary metastasis and no pulmonary metastasis (0% vs.90.7%, P<0.001), complicated with and without tumor thrombus (<66.4% vs. 93.5%, P<0.001) on the effect of 3-year survival rate of the PRCC patients. In this study, there were 16 patients with type 2 PRCC complicated with tumor thrombus. There were significant differences in concomitant symptoms (62.5% vs. 22.0%, P=0.005), maximum tumor diameter (68.8% vs.13.3%, P<0.001), adrenal metastasis (18.8% vs. 0.02%, P=0.029), pulmonary metastasis (18.8% vs. 0%, P=0.008), nuclear grade (P<0.001) and pathological type (100% vs. 44.1%, P<0.001) between the PRCC patients with  and  without tumor thrombus. Conclusion: There were significant differences in tumor diameter,lymph node metastasis,adrenal metastasis,pulmonary metastasis,pathological type,nuclear grade and tumor thrombus in the effect of the 3year survival rate of PRCC patients. PRCC patients with tumor thrombus were more commonly suffered from type 2 PRCC, for whom the tumor diameter was larger,the nuclear grade was higher,and the distance metastasis happened more easily.

Key words: Papillary renal cell carcinoma, Tumor thrombus, Survival rate

中图分类号: 

  • R737.1
[1] 赵勋,颜野,黄晓娟,董靖晗,刘茁,张洪宪,刘承,马潞林. 癌栓粘连血管壁对非转移性肾细胞癌合并下腔静脉癌栓患者手术及预后的影响[J]. 北京大学学报(医学版), 2021, 53(4): 665-670.
[2] 毕海,黄毅,马潞林,陆敏,张树栋,张洪宪. 3例肾尤文肉瘤合并下腔静脉癌栓的诊治[J]. 北京大学学报(医学版), 2020, 52(5): 985-989.
[3] 田晓军,邱敏,刘茁,肖若陶,黄毅,王国良,侯小飞,张树栋,庄申榕,马潞林. 微创手术治疗肾癌合并Mayo 0~2级静脉癌栓的单中心研究[J]. 北京大学学报(医学版), 2018, 50(6): 1053-1056.
[4] 曾鸿,容晓莹,张小青,郭向阳. 肾癌伴下腔静脉癌栓手术中应用回收式自体输血联合白细胞滤器2例[J]. 北京大学学报(医学版), 2017, 49(4): 736-739.
[5] 刘茁,马潞林,田晓军,王国良,侯小飞,张树栋,邓绍晖. 肾癌根治性切除加癌栓取出术治疗Mayo Ⅲ级下腔静脉癌栓的手术技术及临床经验[J]. 北京大学学报(医学版), 2017, 49(4): 597-602.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 田增民, 陈涛, Nanbert ZHONG, 李志超, 尹丰, 刘爽. 神经干细胞移植治疗遗传性小脑萎缩的临床研究(英文稿)[J]. 北京大学学报(医学版), 2009, 41(4): 456 -458 .
[2] 郭岩, 谢铮. 用一代人时间弥合差距——健康社会决定因素理论及其国际经验[J]. 北京大学学报(医学版), 2009, 41(2): 125 -128 .
[3] 成刚, 钱振华, 胡军. 艾滋病项目自愿咨询检测的技术效率分析[J]. 北京大学学报(医学版), 2009, 41(2): 135 -140 .
[4] 卢恬, 朱晓辉, 柳世庆, 郑杰, 邱晓彦. 白细胞介素2促进宫颈癌细胞系HeLaS3免疫球蛋白G的表达[J]. 北京大学学报(医学版), 2009, 41(2): 158 -161 .
[5] 袁惠燕, 张苑, 范田园. 离子交换型栓塞微球及其载平阳霉素的制备与性质研究[J]. 北京大学学报(医学版), 2009, 41(2): 217 -220 .
[6] 徐莉, 孟焕新, 张立, 陈智滨, 冯向辉, 释栋. 侵袭性牙周炎患者血清中抗牙龈卟啉单胞菌的IgG抗体水平的研究[J]. 北京大学学报(医学版), 2009, 41(1): 52 -55 .
[7] 董稳, 刘瑞昌, 刘克英, 关明, 杨旭东. 氯诺昔康和舒芬太尼用于颌面外科术后自控静脉镇痛的比较[J]. 北京大学学报(医学版), 2009, 41(1): 109 -111 .
[8] 祁琨, 邓芙蓉, 郭新彪. 纳米二氧化钛颗粒对人肺成纤维细胞缝隙连接通讯的影响[J]. 北京大学学报(医学版), 2009, 41(3): 297 -301 .
[9] Jian-wei GU, Emily YOUNG, Zhi-jun PAN, Kevan B. TUCKER, Megan SHPARAGO, Min HUANG, Amelia Purser BAILEY. SD大鼠长期高盐饮食可导致其高血压并改变肾细胞因子基因表达谱[J]. 北京大学学报(医学版), 2009, 41(5): 505 -515 .
[10] 李宏亮*, 安卫红*, 赵扬玉, 朱曦. 妊娠合并高脂血症性胰腺炎行血液净化治疗1例[J]. 北京大学学报(医学版), 2009, 41(5): 599 -601 .